CWICX
Price
$60.59
Change
+$0.11 (+0.18%)
Updated
Apr 17 closing price
Net Assets
117.17B
MSFBX
Price
$32.20
Change
-$0.18 (-0.56%)
Updated
Apr 17 closing price
Net Assets
2.56B
Ad is loading...

CWICX vs MSFBX

Header iconCWICX vs MSFBX Comparison
Open Charts CWICX vs MSFBXBanner chart's image
American Funds Capital World Gr&Inc 529C
Price$60.59
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets117.17B
Morgan Stanley Inst Global Franchise A
Price$32.20
Change-$0.18 (-0.56%)
VolumeN/A
Net Assets2.56B
CWICX vs MSFBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWICX vs. MSFBX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWICX is a Buy and MSFBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CWICX has more cash in the bank: 117B vs. MSFBX (2.56B). CWICX pays higher dividends than MSFBX: CWICX (0.87) vs MSFBX (0.43). CWICX was incepted earlier than MSFBX: CWICX (23 years) vs MSFBX (23 years). CWICX (1.53) is less costly to investors than MSFBX (1.17). CWICX is a more actively managed with annual turnover of: 27.00 vs. MSFBX (15.00). CWICX has a lower initial minimum investment than MSFBX: CWICX (250) vs MSFBX (1000). MSFBX annual gain was more profitable for investors over the last year : -0.87 vs. CWICX (-1.69). CWICX return over 5 years is better than : 42.38 vs. MSFBX (27.04).
CWICXMSFBXCWICX / MSFBX
Total Expense Ratio1.531.17131%
Annual Report Gross Expense Ratio1.531.17131%
Fund Existence23 years23 years-
Gain YTD-3.9400.552-713%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B2.56B4,563%
Annual Yield % from dividends0.870.43201%
Returns for 1 year-1.69-0.87195%
Returns for 3 years10.193.12327%
Returns for 5 years42.3827.04157%
Returns for 10 years40.3963.1364%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLAX31.13N/A
N/A
PGIM Jennison Health Sciences A
LGPSX31.33N/A
N/A
ProFunds Large Cap Growth Svc
PRJQX40.63N/A
N/A
PGIM Jennison Global Opportunities R6
MNBRX18.86N/A
N/A
Manning & Napier Pro-Blend Extnd Term R
CEIZX11.82N/A
N/A
Manning & Napier Callodine Equity Inc Z